BrightHeart is a category-defining, AI-software medical device company on a mission to deliver expert level ultrasound care worldwide, regardless of resources, setting, and expertise. The company’s flagship FDA-cleared products apply AI in real time during the ultrasound examination to support exam completeness and abnormality detection, with an initial focus on the fetal heart and a clear vision to support all the major pain points of the prenatal scan.
The company was initially co-founded by two physicians, experts in fetal cardiac ultrasound. We are funded and incubated by Sofinnova MD Start III, an efficient 3-in-1 "accelerator" structure. Their mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and their continued funding. Their team operates the projects and builds new companies to bridge the gap between science and clinical experience. Through this, BrightHeart also benefits from a robust network of strategics, advisors, and investors.
BrightHeart is at an exciting inflection point having secured all the necessary FDA clearances to commercialize our product in the US and already showing solid traction with high-profile commercial partners.
We are currently a lean team with experience in the field, working with expert partners, and funded. We want to move fast by hiring top level talent!